A kan 2021-12-06, lokacin Amurka, Acadia Pharmaceuticals (Nasdaq: ACAD) ta ba da sanarwar ingantattun sakamakon layin farko na gwajin asibiti na Mataki na III na ɗan takararta na magani, Trofinetide.Gwajin lokaci na III, wanda ake kira Lavender, ana amfani da shi musamman don kimanta aminci da ingancin Trofinetide a cikin maganin Ret ...
Kara karantawa